Literature DB >> 178690

Immunoperoxidase technique for detection of antibodies to human cytomegalovirus.

G Gerna, C J McCloud, R W Chambers.   

Abstract

The indirect immunoperoxidase antibody technique (IPA) has been applied to determine immunoglobulin (Ig)G to humans cytomegalovirus (CMV) antibodies in 114 blood donor sera, four cases of congenital cytomegalic inclusion disease, and four cases of acquired CMV infection. The results have been compared with those obtained with the CMV complement fixation (CF) test and indirect fluorescent antibody technique (IFA) for broad spectrum CMV antibody (sigmaAb) detection. IgG antibody has been detected by both CF and IPA. In healthy adult people IPA titers are usually higher than CF titers. In addition, IFA sigmaAb titers are generally higher than CF titers. Some sera negative by CF and IPA are positive at low dilutions by IFA sigmaAb antibody determination, due to the detection of small amounts of IgA or noncomplement-fixing IgG. Nonspecific results seem unlikely, since only nuclear inclusion fluorescence was interpreted as specific, as demonstrated by blocking tests. In acute CMV infection, the IFA sigmaAb and IPA IgG titers are essentially the same, except during the first weeks of infection, when IFA titers are higher and IgM is detectable. No cross-reactivity with other herpes group viruses, herpes simplex and varicella-zoster, was observed. Although some problems of nonspecific staining of cytoplasmic inclusions are shared by both methods, the IPA technique seems to possess the same degree of sensitivity and specificity as the IFA technique, but interpretation is easier and various procedural steps can be delayed without the technical problems associated with fluorescence microscopy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178690      PMCID: PMC274300          DOI: 10.1128/jcm.3.3.364-372.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS.

Authors:  G PLUMMER; M BENYESH-MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  Serologic differentiation of viruses responsible for cytomegalic inclusion disease.

Authors:  T H WELLER; J B HANSHAW; D E SCOTT
Journal:  Virology       Date:  1960-09       Impact factor: 3.616

3.  Cytomegalovirus infections in newborn infants.

Authors:  G Birnbaum; J I Lynch; A M Margileth; W M Lonergan; J L Sever
Journal:  J Pediatr       Date:  1969-11       Impact factor: 4.406

4.  The use of an immunofluorescence technique for the determination of antibodies to cytomegalovirus strains in human sera.

Authors:  W T Chiang; B B Wentworth; E R Alexander
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

5.  Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes.

Authors:  T Ishizaka; K Ishizaka; S Salmon; H Fudenberg
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

6.  Elevated cord macroglobulins in the diagnosis of intrauterine infections.

Authors:  E R Stiehm; A J Ammann; J D Cherry
Journal:  N Engl J Med       Date:  1966-11-03       Impact factor: 91.245

7.  Cytomegaloviremia following congenital infection.

Authors:  D J Lang; B Noren
Journal:  J Pediatr       Date:  1968-12       Impact factor: 4.406

8.  Fluorescent-antibody test for cytomegalovirus macroglobulin.

Authors:  J B Hanshaw; H J Steinfeld; C J White
Journal:  N Engl J Med       Date:  1968-09-12       Impact factor: 91.245

9.  Human cytomegalovirus: properties of the complement-fixing antigen.

Authors:  M Benyesh-Melnick; V Vonka; F Probstmeyer; I Wimberly
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

10.  Determination of the optimal ammonium sulfate concentration for the fractionation of rabbit, sheep, horse, and goat antisera.

Authors:  G A Hebert; P L Pelham; B Pittman
Journal:  Appl Microbiol       Date:  1973-01
View more
  10 in total

1.  Rapid detection of IgG and IgM antibodies for cytomegalovirus by the enzyme linked immunosorbent assay (ELISA).

Authors:  R Cappel; F de Cuyper; J de Braekeleer
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus.

Authors:  H Schmitz; H W Doerr; D Kampa; A Vogt
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

3.  Varicella-zoster plaque assay and plaque reduction neutralization test by the immunoperoxidase technique.

Authors:  G Gerna; R W Chambers
Journal:  J Clin Microbiol       Date:  1976-11       Impact factor: 5.948

4.  Micromodified cytomegalovirus antibody screening test.

Authors:  S M Henry; A M Ramirez; D G Woodfield
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

5.  Immunoglobulin G to virus-specific early antigens in congenital, primary, and reactivated human cytomegalovirus infections.

Authors:  G Gerna; P M Cereda; E Cattaneo; G Achilli; M G Revello
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

Review 6.  Assessment of human cytomegalovirus antibody detection techniques.

Authors:  F Horodniceanu; S Michelson
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus.

Authors:  R V Krishna; O H Meurman; T Ziegler; U H Krech
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

8.  Type specificity and use of human sera for rapid typing of herpes simplex virus isolates by an indirect peroxidase-labeled antibody technique: a comparison with three other methods.

Authors:  G Gerna; J Ditmore; R W Chambers
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

9.  Serodiagnosis of respiratory synctial virus infections in infants and young children by the immunoperoxidse technique.

Authors:  G Gerna; E Cattaneo; P M Cereda; M Grazia Revello; G Achilli
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

10.  Detection of antibodies to varicella zoster virus by radioimmunoassay and enzyme immunoassay techniques.

Authors:  M G Friedman; H Haikin; S Leventon-Kriss; R Joffe; V Goldstein; I Sarov
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.